Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gschwendtner

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Urology|June 24, 1999
Are nuclear texture features a suitable tool for predicting non-organ-confined prostate cancer?T Mairinger, G Mikuz, A Gschwendtner
Lancet (London, England)|November 24, 1999
Underestimated health hazard: proposal for an ergonomic microscope workstationA Kreczy, M Kofler, A Gschwendtner
The Prostate|August 10, 1999
Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinomaT Mairinger, G Mikuz, A Gschwendtner
Journal of Telemedicine and Telecare|January 1, 1997
What do students think about telemedicine?A Gschwendtner, T Netzer, B Mairinger, et al.
Journal of Telemedicine and Telecare|January 1, 1997
The legal situation of telemedicine in AustriaT Mairinger, T Netzer, A Gschwendtner, et al.
Histopathology|February 22, 2005
Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusionA Tzankov, T Brunhuber, A Gschwendtner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 1999
Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometryA Gschwendtner, Y Hoffmann-Weltin, G Mikuz, et al.
Journal of Telemedicine and Telecare|June 26, 1998
Pathologists' attitudes to implementing telepathologyT Mairinger, T T Netzer, W Schoner, et al.
American Journal of Clinical Pathology|October 1, 1994
DNA cytometry: diploid standard and section thicknessA Gschwendtner, A Kreczy, K Prein, et al.
European Urology|May 8, 2001
Consideration of low PSA cut-off levels to optimize the detection of curable prostate cancerW Horninger, H Volgger, H Rogatsch, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Urology|June 24, 1999
Are nuclear texture features a suitable tool for predicting non-organ-confined prostate cancer?T Mairinger, G Mikuz, A Gschwendtner
Lancet (London, England)|November 24, 1999
Underestimated health hazard: proposal for an ergonomic microscope workstationA Kreczy, M Kofler, A Gschwendtner
The Prostate|August 10, 1999
Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinomaT Mairinger, G Mikuz, A Gschwendtner
Journal of Telemedicine and Telecare|January 1, 1997
What do students think about telemedicine?A Gschwendtner, T Netzer, B Mairinger, et al.
Journal of Telemedicine and Telecare|January 1, 1997
The legal situation of telemedicine in AustriaT Mairinger, T Netzer, A Gschwendtner, et al.
Histopathology|February 22, 2005
Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusionA Tzankov, T Brunhuber, A Gschwendtner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 1999
Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometryA Gschwendtner, Y Hoffmann-Weltin, G Mikuz, et al.
Journal of Telemedicine and Telecare|June 26, 1998
Pathologists' attitudes to implementing telepathologyT Mairinger, T T Netzer, W Schoner, et al.
American Journal of Clinical Pathology|October 1, 1994
DNA cytometry: diploid standard and section thicknessA Gschwendtner, A Kreczy, K Prein, et al.
European Urology|May 8, 2001
Consideration of low PSA cut-off levels to optimize the detection of curable prostate cancerW Horninger, H Volgger, H Rogatsch, et al.
Pageof 5